Term
|
Definition
|
|
Term
| Bethanecol (Therapeutic class) |
|
Definition
| Nonobstructive urinary retention agent |
|
|
Term
| Bethanecol (therapeutic use) |
|
Definition
•To increase smooth muscle tone & contractions in GI tract after general anesthesia; treat nonobstructive urinary retention in patients with atony of the bladder. |
|
|
Term
| Bethanecol (pharmacologic class) |
|
Definition
| Muscarinic cholinergic receptor agonist |
|
|
Term
|
Definition
| Direct-acting parasympathomimetic; muscarinic receptor agonist |
|
|
Term
|
Definition
|
|
Term
Atropine (therapeutic class) |
|
Definition
| Antidote for anticholinesterase poisoning |
|
|
Term
| Atropine (therapeutic use) |
|
Definition
| To treat anticholinesterase poisoning |
|
|
Term
| Atropine (pharmacologic class) |
|
Definition
| Muscarinic cholinergic receptor antagonist |
|
|
Term
|
Definition
| Muscarinic receptor antagonist |
|
|
Term
| Phenylephrine (trade name) |
|
Definition
|
|
Term
| Phenylephrine (therapeutic class) |
|
Definition
|
|
Term
| Phenylephrine (therapeutic use) |
|
Definition
| To reduce nasal congestion |
|
|
Term
Phenylephrine (pharm class)
|
|
Definition
|
|
Term
|
Definition
| Nonselective alpha receptor agonist |
|
|
Term
|
Definition
|
|
Term
| Prazosin (therapeutic class) |
|
Definition
|
|
Term
| Prazosin (therapeutic use) |
|
Definition
| In combination with other agents to treat hypertension |
|
|
Term
|
Definition
| Adrenergic-blocking agent |
|
|
Term
|
Definition
| Selective alpha-1 receptor antagonist |
|
|
